servic technolog insur broker
organiz transit track go
summari compani show good progress transit relat sale
matur outsourc busi highlight even greater sign
rotat includ shift higher growth busi abil morph leaner
nimbl organ result acceler revenu strong margin
expans lead peer earn growth convict transit good
come year howev uncertainti around fca investig london make us
less construct stock near term
earn revis decreas earn per share estim
larg higher expect tax rate
oper strength across board close year organ
growth importantli driven strong fundament across virtual
everi oper segment broad exposur risk side continu track favor
key pocket within consult busi continu see strong demand level
well compani achiev basi point margin expans year
larg driven cost save program track ahead schedul sign
point persist trend go
solid earn outlook expect earn per share growth
organ continu ration refocus follow outsourc
divestitur top-lin growth match last year rang
balanc contribut organ growth deal howev could
exceed price increas deal activ acceler current level
similarli margin side expect margin improv save initi
par final expect billion share repurchas
would slowdown form level
watch acquisit activ higher averag
potenti persist above-averag level free cash flow gener alway key
broker moreov headwind restructur charg higher
capit expenditur look least midsingle-digit growth underli cash
flow london market investig potenti signific issu
global broker come find fall invest growth
segment data analyt health solut evid strong
momentum busi would good support compani rotat away
outsourc busi
plc lead global insur broker provid risk manag servic insur reinsur
brokerag human capit consult
return equiti ttm
pleas refer import disclosur page analyst certif page
william blair affili seek busi compani cover research report
result investor awar firm may conflict interest could affect object
report report intend provid person invest advic opinion recommend
herein take account individu client circumst object need intend
recommend particular secur financi instrument strategi particular client recipi
report must make independ decis regard secur financi instrument mention
expect earn per share growth largest driver earn expans margin
improv expect basi point annual improv larg driven cost
reduct initi organ growth like continu momentum expect organ growth
compar complement top-lin growth steadi acquisit level drove busi
expans expect step deal look top-lin growth acquisit
compani continu deploy build cash come sale outsourc busi anoth import level
cash deploy share buyback compani repurchas billion share expect
anoth billion billion repurchas like factor aggreg add least
earn per share
like broker peer exhibit strong underli growth past coupl year trend continu
well importantli seen strong organ growth across segment commerci risk solut
segment saw acceler growth fourth quarter compar year-to-d averag closer exposur
gener posit captiv manag busi perform particularli well price flat
neg go exposur remain tailwind busi expect growth
year could exceed price pick reinsur busi particularli strong well report
organ growth driven growth treati placement faculti placement although fourth quarter
includ degre non-recurring benefit reinstat premium retir solut larg driven
deleg manag busi asset manag growth billion start
year almost prior year demand servic continu well expect
underli growth segment next month health solut data analyt segment
strongest organ grower driven global demand benefit brokerag well pick affinity- claims-
relat revenu data analyt segment particular inher higher growth natur continu
grow organ elev level addit type higher-growth area continu
acquisit go forward
compani file william blair compani aon plcep growth ep william blair
aon acquisit growth pick expect see behavior acquisit growth
neg net disposit use proce sale compani outsourc busi
reenerg activ total compani deploy billion toward deal expect
similar level result top-lin growth deal rang revenu growth includ
deal organ growth easili match last year rang possibl upsid
potenti number unit exposur increas nomin growth domest
abroad continu price impact could boost organ growth beyond expect
addit plenti dri powder deal activ could pick compani see buy opportun
adjust oper margin show substanti improv pois similar better
improv save larg revolv around compani effort streamlin technolog system premis
cost peopl support compani achiev million run-rat cost save core driver
basi point margin expans year expect similar level cost save drive least
anoth basi point margin improv howev could conserv compani increas cost-
save hurdl result program addit expect save slate come compani
track ahead expect pace possibl save achiev could better
expect acquisit like factor margin progress well typic increas acquisit could
result lower margin non-recurring cost complet deal weigh near term howev compani
risk analyt compani file william blair compani caon plcorgan growth segment compani file william blair compani caon plcannual growth growthorgan growth william blair
success past invest higher-growth higher-margin busi possibl busi acquir
higher margin could off-set transact cost near term even extent margin neg affect
deal reacceler margin like follow soon compani materi step acquisit
effort possibl deal off-set would typic repres margin expans strong organ
growth margin expans improv entir driven program save howev revers trend
could allow addit margin expans come year could bring upsid estim
save improv yoy margin compani file william blair compani caon plcmargin trend william blair
plc modelrevenu time comp cost reflect chang start statementbrokerag comm invest organ depreci fix gener oper expens oper adjust oper interest incom adj p-t incom tax rate effect tax net minor adjust net oper incom report taxes- discontinu ops- net incom gaap- net incom attribut net incom per share outstand per share start common share share repurchas share share import disclosur
